Why is Ipca Labs falling/rising?

As of 16-Jul, Ipca Laboratories Ltd is currently priced at 1,462.65, reflecting a decrease of 3.15 points or 0.21%. The stock has experienced a trend reversal, falling after two consecutive days of gains. Despite this decline, it has shown a positive performance over the past month, with a return of 7.41%, significantly outperforming the Sensex, which returned only 1.02% in the same period. The stock's liquidity appears adequate, with a delivery volume increase of 225.23% against the 5-day average, indicating rising investor participation. Additionally, the company has demonstrated strong fundamentals, with a low debt-to-equity ratio and positive results over the last four quarters, including a remarkable 119.56% growth in profit after tax.
In the broader market context, while the stock has underperformed year-to-date with a decline of 13.53% compared to the Sensex's gain of 5.75%, it has outperformed the market over the past year with a return of 19.78% against the BSE500's 2.38%. This suggests that despite the recent price drop, the stock has a history of strong performance and high institutional holdings at 46.82%, which may provide a buffer against volatility. Overall, the current decline seems to be a short-term fluctuation rather than a reflection of the company's long-term potential, especially given its recent positive financial results and market-beating performance.